Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy

Gene Therapy

Volumn 6, Issue 6, 1999, Pages 1038-1044

  Matsuda, K M ^a,c   Kume, A ^a,c   Ueda, Y ^a,c,d   Urabe, M ^a,c   Hasegawa, M ^d   Ozawa, K ^a,b,c  

^a Center for Molecular Medicine   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d DNAVEC Research Inc   (Japan)

Author keywords

Estrogen inducible proliferation; Gene therapy; Hematopoietic stem cells; Selective amplifier gene

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; PHENYLALANINE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHIMERA; GENE AMPLIFICATION; GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; CELL DIVISION; CELL LINE; CELL SIZE; GENE AMPLIFICATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; MICE; RATS;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0032982941     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300906     Document Type: Article

References (30)

1. Karlsson S. Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 1991; 78: 2481-2492.
2. Dunbar CE, Emmons RVB. Gene transfer into hematopoietic progenitor and stem cells: progress and problems. Stem Cells 1994; 12: 563-576.
3. Havenga M, Hoogerbrugge P, Valerio D, Van Es HHG. Retroviral stem cell gene therapy. Stem Cells 1997; 15: 162-179.
4. + cells in ADA-deficient SCID neonates. Nature Med 1998; 4: 775-780.
5. Ito K et al. Development of a novel selective amplifier gene for controllable expansion of transduced hematopoietic cells. Blood 1997; 90: 3884-3892.
6. Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996; 88: 761-777
7. Parker MG et al. Structure and function of the estrogen receptor. Ann NY Acad Sci 1993; 684: 119-126.
8. Mattioni T, Louvion J-F, Picard D. Regulation of protein activities by fusion to steroid binding domains. Meth Cell Biol 1994; 43: 335-352.
9. Fukunaga R et al. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J 1991; 10: 2855-2865.
10. Dong F et al. Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol 1993; 13: 7774-7781.
11. Fukunaga R, Ishizaka-Ikeda E, Nagata S. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell 1993; 74: 1079-1087.
12. Yoshikawa A, Murakami H, Nagata S. Distinct signal transduction through the tyrosine-containing domains of the granulocyte colony-stimulating factor receptor. EMBO J 1995; 14: 5288-5296.
13. Fukunaga R, Ishizaka-Ikeda E, Seto Y, Nagata S. Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 1990; 61: 341-350.
14. Koike S, Sakai M, Muramatsu M. Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res 1987; 15: 2499-2513.
15. Onishi M et al. Applications of retrovirus-mediated expression cloning. Exp Hematol 1996; 24: 324-329.
16. Duke GM, Hoffman MA, Palmenberg AC. Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation. J Virol 1992; 66: 1602-1609.
17. Nakauchi H et al. Molecular cloning of Lyt-2, a membrane glycoprotein marking a subset of mouse T lymphocytes: molecular homology to its human counterpart, Leu-2/T8, and to immunoglobulin variable regions. Proc Natl Acad Sci USA 1985; 82: 5126-5130.
18. Valtieri M et al. Cytokine-dependent granulocytic differentiation: regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol 1987; 138: 3829-3835.
19. Albritton LM, Tseng L, Scadden D, Cunningham JM. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1989; 57: 659-666.
20. Scudiero DA et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988; 48: 4827-4833.
21. De Koning JP et al. Proliferation signaling and activation of Shc, p21Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood 1998; 91: 1924-1933.
22. Sorrentino BP et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 1992, 257: 99-103.
23. Blau CA, Peterson KR, Drachman JG, Spencer DM. A proliferation switch for genetically modified cells. Proc Natl Acad Sci USA 1997; 94: 3076-3081.
24. Jin L, Asano H, Blau CA. Stimulating cell proliferation through the pharmacologic activation of c-kit. Blood 1998; 91: 890-897.
25. Kodaira H et al. Fas and mutant estrogen receptor chimeric gene: a novel suicide vector for tamoxifen-inducible apoptosis. Jpn J Cancer Res 1998; 89: 741-747.
26. Gorman CM et al. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DMA-mediated transfection. Proc Natl Acad Sci USA 1982; 79: 6777-6781.
27. Fung MC et al. Molecular cloning of cDNA for murine interleukin-3. Nature 1984; 307: 233-237.
28. Blochlinger K, Diggelmann H. Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eukaryotic cells. Mol Cell Biol 1984; 4: 2929-2931.
29. Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 1988; 18: 97-104.
30. Gorman C, Padmanbhan R, Howard BH. High efficiency DNA-mediated transformation of primate cells. Science 1983, 221. 551-553.